Report Company Directory
- Albany Molecular Research, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report by MarketLine
- Moody's assigns B3 CFR to UIC Merger Sub, Inc. (dba Albany Molecular Research, Inc.) by Moody's Investors Service
- INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information by BusinessWire
- The Law Offices of Vincent Wong Reminds Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group by BusinessWire
- The Law Offices of Vincent Wong Notifies Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group by BusinessWire
- Albany Molecular Research, Inc.: Update to Discussion of Key Rating Factors by Moody's Investors Service
- SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information by BusinessWire
- INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders by BusinessWire
- Albany Molecular Research, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with The Carlyle Group by BusinessWire
- Moody's places Albany Molecular's ratings on review for downgrade by Moody's Investors Service